BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9413927)

  • 21. From MIF-1 to endomorphin: the Tyr-MIF-1 family of peptides.
    Pan W; Kastin AJ
    Peptides; 2007 Dec; 28(12):2411-34. PubMed ID: 17988762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of hematopoietic progenitor cell growth by Tyr-MIF, an endogenous opiate modulator, and its degradation products.
    Horowitz D; Callahan JF; Pelus LM; Fukuda S; King AG
    Int Immunopharmacol; 2002 Apr; 2(5):721-30. PubMed ID: 12013510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyr-MIF-1 binding in brain is not altered by ligands selective for the GABAA/benzodiazepine receptor.
    Zadina JE; Kastin AJ; Ge LJ
    Neurosci Lett; 1990 Mar; 110(1-2):143-7. PubMed ID: 1970141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide transport system-1 (PTS-1) for Tyr-MIF-1 and Met-enkephalin differs from the receptors for either.
    Maresh GA; Kastin AJ; Brown TT; Zadina JE; Banks WA
    Brain Res; 1999 Aug; 839(2):336-40. PubMed ID: 10519058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of Tyr-MIF-1 to isolated brain capillaries.
    Pretorius HT; Kastin AJ; Banks WA
    Brain Res Bull; 1986 Dec; 17(6):829-31. PubMed ID: 2879616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: comparison with morphine.
    Banks WA; Kastin AJ
    Peptides; 1994 Jan; 15(1):23-9. PubMed ID: 7912427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the FOS proto-oncogene protein in brain after ICV administration of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2).
    Gergen KA; Chang SL; Niu YF; Kastin AJ; Zadina JE
    Peptides; 1994; 15(8):1505-11. PubMed ID: 7700853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of neonatal treatment with Tyr-MIF-1, morphiceptin, and morphine on development, tail flick, and blood-brain barrier transport.
    Harrison LM; Zadina JE; Banks WA; Kastin AJ
    Brain Res Dev Brain Res; 1993 Oct; 75(2):207-12. PubMed ID: 7903224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tyr-MIF-1 augments benzodiazepine receptor binding in vivo.
    Miller LG; Kastin AJ; Greenblatt DJ
    Pharmacol Biochem Behav; 1987 Dec; 28(4):521-4. PubMed ID: 2893390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Tyr-MIF-1 family of peptides.
    Reed GW; Olson GA; Olson RD
    Neurosci Biobehav Rev; 1994; 18(4):519-25. PubMed ID: 7708364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyr-W-MIF-1-induced conditioned place preference.
    Nores WL; Olson RD; Olson GA; Vaccarino AL; Bell RL; Zadina JE; Kastin AJ
    Peptides; 1999; 20(4):479-84. PubMed ID: 10458518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural specificity of MIF-1 and Tyr-MIF-1 in augmenting GABA-stimulated benzodiazepine receptor binding.
    Miller LG; Kastin AJ; Roy RB; Gaver A; Fischman AJ; Horvath A
    Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):365-8. PubMed ID: 2908009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine receptor antagonists block the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia.
    Krowicki ZK
    Neuropeptides; 1991 Aug; 19(4):281-5. PubMed ID: 1681456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tyr-MIF-1 acts as an opiate antagonist in the tail-flick test.
    Kastin AJ; Stephens E; Ehrensing RH; Fischman AJ
    Pharmacol Biochem Behav; 1984 Dec; 21(6):937-41. PubMed ID: 6151669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cimetidine does not change the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia.
    Krowicki ZK
    Life Sci; 1991; 49(16):1163-8. PubMed ID: 1680211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypophysectomy increases TYR-MIF-1-like immunoreactivity in rat plasma.
    Kastin AJ; Dickson JC
    Neuroendocrinology; 1987 Mar; 45(3):177-81. PubMed ID: 2882434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MIF-1 and Tyr-MIF-1 fail to alter benzodiazepine-induced hypothermia.
    Kastin AJ; Miller LG; Schwartzenburg DS
    Pharmacol Biochem Behav; 1989 May; 33(1):261-3. PubMed ID: 2571169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia.
    Hagan MM; Moss DE
    Peptides; 1994; 15(2):243-5. PubMed ID: 7911993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for presence of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in human brain cortex.
    Horvath A; Kastin AJ
    Int J Pept Protein Res; 1990 Sep; 36(3):281-4. PubMed ID: 1980671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.